Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
According to court records in a West Virginia case, AmerisourceBergen executives shared one email that referred to the prescription opioid Oxycontin as “hillbilly heroin.”
According to data from MarketBeat, AmerisourceBergen currently has an average rating of “Moderate Buy” and an average price target of $181.
AmerisourceBergen Co. has a 12 month low of $134.70 and a 12 month high of $174.63.
AmerisourceBergen Co. has a 1 year low of $135.14 and a 1 year high of $193.43.
AmerisourceBergen had a return on equity of 444.46% and a net margin of 0.71%.
Empowered Funds LLC acquired a new position in AmerisourceBergen during the 4th quarter worth $908,000.
Finally, Morgan Stanley upped their target price on AmerisourceBergen from $176.00 to $190.00 and gave the company an “equal weight” rating in a research report on Thursday, August 3rd.
Finally, Truvestments Capital LLC acquired a new position in shares of AmerisourceBergen during the 2nd quarter valued at $53,000.
Guggenheim Capital LLC cut its stake in shares of AmerisourceBergen Co. () by 13.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.
In January, a well-attended Opioid Solutions Forum was hosted by the Valparaiso City Council to gather information for the use of funding provided as part of a national settlement with Johnson & Johnson, AmerisourceBergen, Cardinal Health and McKesson.
In other AmerisourceBergen news, EVP sold 1,924 shares of the firm’s stock in a transaction on Wednesday, March 1st.
Raymond James Trust N.A. boosted its holdings in AmerisourceBergen by 29.9% during the first quarter.
Rhumbline Advisers grew its holdings in AmerisourceBergen by 24.8% in the first quarter.
Russell Investments Group Ltd. raised its stake in AmerisourceBergen by 26.2% in the 4th quarter.
TheStreet downgraded shares of AmerisourceBergen from a “b-” rating to a “c” rating in a research report on Monday, March 6th.